MarketCap
Facebook
X
TelegramQuarterly report 2026-Q3
added 05-11-2026
FONAR Corporation Total Shareholders Equity 2011-2026 | FONR
Annual Total Shareholders Equity FONAR Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 173 M | 166 M | 158 M | 150 M | 138 M | 126 M | 116 M | 102 M | 82.9 M | 60.8 M | 50.8 M | 45.9 M | 37.8 M | 11.1 M | 5.87 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 173 M | 5.87 M | 95 M |
Quarterly Total Shareholders Equity FONAR Corporation
| 2026-Q3 | 2026-Q2 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 179 M | 177 M | 177 M | 175 M | 170 M | 172 M | 170 M | 159 M | 164 M | 157 M | 156 M | 154 M | 154 M | 151 M | 148 M | 147 M | 150 M | 148 M | 142 M | 139 M | 135 M | 138 M | 134 M | 129 M | 126 M | 126 M | 124 M | 121 M | 116 M | 116 M | 110 M | 102 M | 98.7 M | 92.6 M | 90 M | - | 82.9 M | - | - | - | 60.8 M | - | - | - | 50.8 M | - | - | - | 45.9 M | 43.4 M | 42.1 M | 40.3 M | 37.8 M | 37.8 M | 14.1 M | 12.6 M | 11.1 M | 11.1 M | 9.18 M | 7.45 M | 5.88 M | 5.87 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 179 M | 5.87 M | 105 M |
Total Shareholders Equity of other stocks in the Medical devices industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cutera
CUTR
|
-172 M | - | -10.19 % | $ 1.99 M |  USA |
 |
EDAP TMS S.A.
EDAP
|
40.9 M | - | - | $ 162 M |  France |
 |
Avinger
AVGR
|
-6.2 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
638 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
101 M | - | - | $ 10.2 M | USA |
 |
Allied Healthcare Products
AHPI
|
5.23 M | - | 3.58 % | $ 2.21 M | USA |
 |
ClearPoint Neuro
CLPT
|
28 M | $ 13.44 | -2.89 % | $ 381 M | USA |
 |
Apollo Endosurgery
APEN
|
32.6 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
12.4 M | $ 8.28 | 1.85 % | $ 1.24 B | USA |
 |
Aziyo Biologics
AZYO
|
27.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
133 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
-247 K | - | -13.19 % | $ 166 K | USA |
 |
IRIDEX Corporation
IRIX
|
4.92 M | $ 1.12 | - | $ 19 M | USA |
 |
Conformis
CFMS
|
54.2 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
249 M | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
301 M | $ 1.54 | 1.99 % | $ 34 M | USA |
 |
LivaNova PLC
LIVN
|
1.2 B | $ 79.39 | -0.69 % | $ 4.33 B |  Britain |
 |
Cytosorbents Corporation
CTSO
|
5.9 M | $ 0.4 | 3.01 % | $ 24.9 M | USA |
 |
Pulmonx Corporation
LUNG
|
54.1 M | $ 1.37 | -3.52 % | $ 55.7 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
347 M | $ 17.82 | -0.06 % | $ 418 M | USA |
 |
Delcath Systems
DCTH
|
111 M | $ 11.72 | -0.38 % | $ 420 M | USA |
 |
Neovasc
NVCN
|
52.2 M | - | - | $ 111 M |  Canada |
 |
LENSAR
LNSR
|
-26 M | $ 5.82 | - | $ 69.6 M | USA |
 |
Dynatronics Corporation
DYNT
|
3.26 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
43.2 M | $ 37.14 | -1.25 % | $ 314 M | USA |
 |
MiMedx Group
MDXG
|
257 M | $ 3.6 | -2.44 % | $ 532 M | USA |
 |
Butterfly Network
BFLY
|
196 M | $ 5.54 | -2.46 % | $ 1.37 B | USA |
 |
Second Sight Medical Products
EYES
|
15.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Myomo
MYO
|
11.4 M | $ 1.15 | -16.06 % | $ 48.1 M | USA |
 |
GBS
GBS
|
3 M | - | -0.57 % | $ 7.12 M | USA |
 |
Orthofix Medical
OFIX
|
450 M | $ 9.31 | 0.87 % | $ 369 M |  Curacao |
 |
Globus Medical
GMED
|
4.57 B | $ 80.39 | -0.16 % | $ 10.9 B | USA |
 |
Insulet Corporation
PODD
|
1.52 B | $ 149.7 | 0.34 % | $ 10.5 B | USA |
 |
Profound Medical Corp.
PROF
|
66.4 M | $ 6.63 | -0.38 % | $ 200 M | Canada |
 |
CONMED Corporation
CNMD
|
1.03 B | $ 34.77 | 1.05 % | $ 1.08 B | USA |
 |
Inspire Medical Systems
INSP
|
781 M | $ 42.7 | 0.61 % | $ 1.25 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.75 B | $ 90.98 | -1.22 % | $ 3.16 B | USA |
 |
Invacare Corporation
IVC
|
81.1 M | - | - | $ 24.7 M | USA |
 |
TransMedics Group
TMDX
|
473 M | $ 72.91 | -0.92 % | $ 2.48 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
10.3 B | $ 85.11 | -0.76 % | $ 49.8 B | USA |